HLS Therapeutics, Inc.
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
- Vaccines
Other Names/Subsidiaries
- Heritage Life Sciences
- Heritage R&D
- HLS Therapeutics USA
Latest on HLS Therapeutics, Inc.
After never fully implementing or enforcing the Risk Evaluation and Mitigation Strategy for clozapine, the US Food and Drug Administration is asking two advisory committees whether the system is still
CG Oncology, Inc. led the latest group of private biotechnology companies that completed $100m-plus venture capital mega-rounds, with a $120m series E financing announced on 15 November, followed clo
The US Food and Drug Administration has temporarily suspended requirements of the modified Clozapine Risk Evaluation and Mitigation Strategy so pharmacists can dispense the antipsychotic without a REM
Billions of dollars flowed into biopharmaceutical companies in the first full week of January with $5.5bn in new funding for private and public drug developers revealed in new investment funds, includ